SCHEMBL28569818

SCHEMBL28569818

CN1CCN(c2ccc(C(=O)OC(C)(C)C)cc2)C(N)C1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
GPR119 Q8TDV5 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
USP30 Q70CQ3 1/20 0.35
SCN1A P35498 2/20 0.35
SCN2A Q99250 2/20 0.35
SCN3A Q9NY46 2/20 0.35
HRH3 Q9Y5N1 1/20 0.35
ALOX15 P16050 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CACNA1B Q00975 1/20 0.34
SRD5A1 P18405 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27807000 0.88 ALDH1A1 (0.44) GPR119L3MBTL1SCN1ASCN2ASCN3A
SCHEMBL28900104 0.85 ALDH1A1 (0.49) CA12CA1CA2CA9CA14
SCHEMBL28576696 0.83 GPR119 (0.38) CA12CA1CA2CA9CA14
SCHEMBL28569815 0.81 ALDH1A1 (0.38) CA12CA1CA2CA9CA14
SCHEMBL28974951 0.75 GPR119 (0.38) CA12CA1CA2CA9CA14
SCHEMBL2409983 0.74 GPR119 (0.51) CA12CA1CA2CA9CA14
SCHEMBL2409985 0.74 GPR119 (0.51) CA12CA1CA2CA9CA14
SCHEMBL5207933 0.73 GPR119 (0.56) CA12CA1CA2CA9CA14
SCHEMBL27898038 0.71 GPR119 (0.43) CA12CA1CA2CA9CA14
SCHEMBL22692234 0.70 GPR119 (0.42) CA12CA1CA2CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939897-A Preparation method and application of broad-spectrum anti-cancer drug enrotinib intermediate 上海珈睿医药科技有限公司 2021-06-11 CN disclosed